Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up.
Journal
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
pubmed:
26
6
2018
medline:
3
9
2019
entrez:
26
6
2018
Statut:
ppublish
Résumé
Giant prolactinomas represent a rare entity of pituitary tumors so that the management of these patients is still a prevalent challenge at present. Paying special attention to the treatment strategy and outcomes, we presented a large series of 42 cases looking forward to share our understanding and experience in management of these patients. Male patients accounted for 71.4% of this series and were relatively younger (35.70±2.42 vs. 52.00±3.55 years, p=0.0011) and harbored bigger tumors (14.57 vs. 7.74 cm
Substances chimiques
Dopamine Agonists
0
Bromocriptine
3A64E3G5ZO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
295-302Informations de copyright
© Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.